These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23700090)

  • 1. EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy.
    Povsic TJ; Najjar SS; Prather K; Zhou J; Adams SD; Zavodni KL; Kelly F; Melton LG; Hasselblad V; Heitner JF; Raman SV; Barsness GW; Patel MR; Kim RJ; Lakatta EG; Harrington RA; Rao SV
    J Thromb Thrombolysis; 2013 Nov; 36(4):375-83. PubMed ID: 23700090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.
    Leone AM; Rutella S; Giannico MB; Perfetti M; Zaccone V; Brugaletta S; Garramone B; Niccoli G; Porto I; Liuzzo G; Biasucci LM; Bellesi S; Galiuto L; Leone G; Rebuzzi AG; Crea F
    Int J Cardiol; 2008 Nov; 130(3):457-62. PubMed ID: 18667247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI 3-kinase-dependent manner.
    George J; Goldstein E; Abashidze A; Wexler D; Hamed S; Shmilovich H; Deutsch V; Miller H; Keren G; Roth A
    Cardiovasc Res; 2005 Nov; 68(2):299-306. PubMed ID: 16048724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice: effects on transplanted cell survival and autologous endothelial progenitor cell mobilization.
    Cheng Y; Hu R; Lv L; Ling L; Jiang S
    J Surg Res; 2012 Jul; 176(1):e47-55. PubMed ID: 22595018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs.
    Hirata A; Minamino T; Asanuma H; Fujita M; Wakeno M; Myoishi M; Tsukamoto O; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Shiraga M; Kitakaze M; Hori M
    J Am Coll Cardiol; 2006 Jul; 48(1):176-84. PubMed ID: 16814664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage.
    Marfella R; Rizzo MR; Siniscalchi M; Paolisso P; Barbieri M; Sardu C; Savinelli A; Angelico N; Del Gaudio S; Esposito N; Rambaldi PF; D'Onofrio N; Mansi L; Mauro C; Paolisso G; Balestrieri ML
    Int J Cardiol; 2013 Oct; 168(4):3954-62. PubMed ID: 23876463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells.
    Prunier F; Pfister O; Hadri L; Liang L; Del Monte F; Liao R; Hajjar RJ
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H522-9. PubMed ID: 16997893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study.
    Taniguchi N; Nakamura T; Sawada T; Matsubara K; Furukawa K; Hadase M; Nakahara Y; Nakamura T; Matsubara H
    Circ J; 2010 Nov; 74(11):2365-71. PubMed ID: 20834185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of myocardial postconditioning on the recruitment of endothelial progenitor cells.
    Jung C; Sörensson P; Saleh N; Arheden H; Rydén L; Pernow J
    J Interv Cardiol; 2012 Apr; 25(2):103-10. PubMed ID: 22320186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.
    Melloni C; Rao SV; Povsic TJ; Melton L; Kim RJ; Kilaru R; Patel MR; Talan M; Ferrucci L; Longo DL; Lakatta EG; Najjar SS; Harrington RA
    Am Heart J; 2010 Nov; 160(5):795-803.e2. PubMed ID: 21095264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
    Najjar SS; Rao SV; Melloni C; Raman SV; Povsic TJ; Melton L; Barsness GW; Prather K; Heitner JF; Kilaru R; Gruberg L; Hasselblad V; Greenbaum AB; Patel M; Kim RJ; Talan M; Ferrucci L; Longo DL; Lakatta EG; Harrington RA;
    JAMA; 2011 May; 305(18):1863-72. PubMed ID: 21558517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Porto I; De Maria GL; Leone AM; Dato I; D'Amario D; Burzotta F; Niccoli G; Trani C; Biasucci LM; Bolognese L; Crea F
    Am J Cardiol; 2013 Sep; 112(6):782-91. PubMed ID: 23746481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial.
    Prunier F; Bière L; Gilard M; Boschat J; Mouquet F; Bauchart JJ; Charbonnier B; Genée O; Guérin P; Warin-Fresse K; Durand E; Lafont A; Christiaens L; Abi-Khalil W; Delépine S; Benard T; Furber A
    Am Heart J; 2012 Feb; 163(2):200-7.e1. PubMed ID: 22305837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke.
    Yip HK; Tsai TH; Lin HS; Chen SF; Sun CK; Leu S; Yuen CM; Tan TY; Lan MY; Liou CW; Lu CH; Chang WN
    Crit Care; 2011; 15(1):R40. PubMed ID: 21269484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial.
    Ludman AJ; Yellon DM; Hasleton J; Ariti C; Babu GG; Boston-Griffiths E; Venugopal V; Walker M; Holdright D; Swanton H; Crake T; Brull D; Moon JC; Puranik R; Muthurangu V; Taylor A; Hausenloy DJ
    Heart; 2011 Oct; 97(19):1560-5. PubMed ID: 21900585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and rationale of low-dose erythropoietin in patients with ST-segment elevation myocardial infarction (EPO-AMI-II study): a randomized controlled clinical trial.
    Minamino T; Toba K; Higo S; Nakatani D; Hikoso S; Umegaki M; Yamamoto K; Sawa Y; Aizawa Y; Komuro I;
    Cardiovasc Drugs Ther; 2012 Oct; 26(5):409-16. PubMed ID: 22940818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome.
    Jie KE; van der Putten K; Bergevoet MW; Doevendans PA; Gaillard CA; Braam B; Verhaar MC
    Heart; 2011 Jan; 97(1):60-5. PubMed ID: 21071558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis.
    Stein A; Mohr F; Laux M; Thieme S; Lorenz B; Cetindis M; Hackl J; Groha P; Demetz G; Schulz S; Mehilli J; Schömig A; Kastrati A; Ott I
    Thromb Haemost; 2012 Apr; 107(4):769-74. PubMed ID: 22318706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial progenitor cells and left ventricle function in patients with acute myocardial infarction: potential therapeutic considertions.
    Kuliczkowski W; Derzhko R; Prajs I; Podolak-Dawidziak M; Serebruany VL
    Am J Ther; 2012 Jan; 19(1):44-50. PubMed ID: 20535003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of methods for assessment of circulating endothelial progenitor cells.
    George J; Shmilovich H; Deutsch V; Miller H; Keren G; Roth A
    Tissue Eng; 2006 Feb; 12(2):331-5. PubMed ID: 16548691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.